Valuation: Alkem Laboratories Limited

Market Cap 591B 6.23B 5.56B 5.14B 4.66B 8.71B 8.86B 61.86B 24.49B 310B 23.38B 22.89B 977B P/E 2027 *
25.8x
P/E 2028 * 22.4x
Enterprise Value 578B 6.09B 5.44B 5.03B 4.55B 8.52B 8.66B 60.48B 23.95B 303B 22.86B 22.38B 955B EV / Sales 2027 *
3.46x
EV / Sales 2028 * 3.03x
Free-Float
38.63%
Yield 2027 *
1.02%
Yield 2028 * 1.12%
1 day-1.33%
1 week-2.04%
Current month-4.19%
1 month-8.68%
3 months-11.69%
6 months-10.39%
Current year-10.16%
1 week 4,811
Extreme 4811
5,099.5
1 month 4,811
Extreme 4811
5,407
Current year 4,811
Extreme 4811
5,933.5
1 year 4,811
Extreme 4811
5,933.5
3 years 3,509.95
Extreme 3509.95
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 44 08/08/2013
Director/Board Member 63 10/02/2008
Director/Board Member 45 10/11/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%-2.04%-10.61%+39.99% 6.23B
-2.54%+1.31%+55.10%+120.84% 1,135B
-1.42%+3.23%+37.07%+74.26% 636B
+0.16%+0.08%+25.14%+97.36% 505B
-0.31%+3.09%+43.92%+64.55% 378B
-1.34%-0.47%+66.63%+40.56% 358B
-0.68%+2.65%+22.46%+51.48% 295B
-1.20%+3.04%+2.62%+26.97% 266B
-1.79%+1.57%+49.97%+60.87% 237B
-0.73%-0.10%+29.24%+101.19% 193B
Average -0.73%+1.75%+32.16%+67.81% 401.06B
Weighted average by Cap. -0.26%+2.65%+40.91%+82.06%

Financials

2027 *2028 *
Net sales 167B 1.76B 1.57B 1.45B 1.31B 2.46B 2.5B 17.46B 6.91B 87.47B 6.6B 6.46B 276B 186B 1.96B 1.75B 1.62B 1.46B 2.74B 2.79B 19.45B 7.7B 97.46B 7.35B 7.2B 307B
Net income 23.15B 244M 218M 201M 182M 341M 347M 2.42B 958M 12.13B 915M 896M 38.23B 27.28B 287M 257M 237M 215M 402M 409M 2.85B 1.13B 14.29B 1.08B 1.06B 45.05B
Net Debt -13.12B -138M -123M -114M -103M -193M -197M -1.37B -543M -6.88B -519M -508M -21.68B -28.19B -297M -265M -245M -222M -415M -422M -2.95B -1.17B -14.77B -1.11B -1.09B -46.56B
Projected Income Statement - Annual - Alkem Laboratories Limited
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
23/10/26 ₹4,947.00 -1.33% 54,982
22/10/26 ₹5,013.50 -0.03% 49,335
21/10/26 ₹5,015.00 +0.22% 279,107
19/10/26 ₹5,004.00 -0.91% 95,218
16/10/26 ₹5,050.00 -1.38% 160,798
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Alkem Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
4,947.00INR
Average target price
6,002.55INR
Spread / Average Target
+21.34%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Alkem Laboratories Limited
  1. Stock Market
  2. Stocks
  3. ALKEM Stock